| Title |
Low-dose decitabine vs. best supportive care in elderly patients |
| Scientific Title |
Intravenous low-dose decitabine versus supportive care in elderly patients with primary Myelodysplastic Syndrome (MDS) (>10 % blasts or high-risk cytogenetics), secondary MDS or Chronic Myelomonocytic Leukemia (CMML) who are not eligible for intensive therapy: an EORTC-German MDS Study Group randomized phase III study |
| Short Title |
MDS EORTC06011 (Elderly) |
| Trialgroup |
Deutsche MDS / German MDS |
| Type of Trial |
randomized |
| Disease |
Myelodysplastic Syndrome(MDS) All subtypes
|
| Age |
>= 60 years |
| Status |
Active |
| Start of Recruitment |
23.05.2002 |
| Leader |
Lübbert, Prof. Dr. med., M. |
| Centre of Trial |
Universitätsklinikum Freiburg |
| Shortprotocol |
Shortprotocol |
created 